HS_SW01 cells injection

DRUG3 trials

Sponsors

Shenzhen Huishan Biotechnology Co., Ltd.

Conditions

Ankylosing SpondylitisPrimary Ovarian Insufficiency (Poi)Systemic Sclerosis (SSc)

Phase 1

A Phase I/Ⅱ Clinical Trial for Umbilical Cord Mesenchymal Stem Cells (UC-MSC) in the Treatment of Ankylosing Spondylitis

Not yet recruitingNCT07534644

Shenzhen Huishan Biotechnology Co., Ltd.Ankylosing Spondylitis

Start: 2026-04-10End: 2027-12-31Target: 18Updated: 2026-04-20

Umbilical Cord Mesenchymal Stem Cells (UC-MSC) in the Treatment of Systemic Sclerosis

Not yet recruitingNCT07535931

Shenzhen Huishan Biotechnology Co., Ltd.Systemic Sclerosis (SSc)

Start: 2026-04-10End: 2027-12-31Target: 21Updated: 2026-04-21

Umbilical Cord Mesenchymal Stem Cells (UC-MSC) in the Treatment of Primary Ovarian Insufficiency

Not yet recruitingNCT07551895

Shenzhen Huishan Biotechnology Co., Ltd.Primary Ovarian Insufficiency (Poi)

Start: 2026-04-15End: 2027-12-31Target: 21Updated: 2026-04-27